Bessemer Group’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.81M | Sell |
186,321
-188,370
| -50% | -$9.68M | 0.01% | 428 |
|
|
2026
Q1 | $22.2M | Buy |
374,691
+64,760
| +21% | +$4.2M | 0.03% | 272 |
|
|
2025
Q4 | $19.1M | Buy |
309,931
+32,331
| +12% | +$1.98M | 0.03% | 287 |
|
|
2025
Q3 | $17.3M | Sell |
277,600
-100,620
| -27% | -$7M | 0.03% | 275 |
|
|
2025
Q2 | $30.2M | Buy |
378,220
+16,262
| +4% | +$1.36M | 0.05% | 218 |
|
|
2025
Q1 | $31.1M | Buy |
361,958
+66,908
| +23% | +$5.49M | 0.06% | 209 |
|
|
2024
Q4 | $23M | Buy |
295,050
+292,144
| +10,053% | +$22.7M | 0.04% | 242 |
|
|
2024
Q3 | $209K | Buy |
2,906
+22
| +0.8% | +$1.56K | ﹤0.01% | 1104 |
|
|
2024
Q2 | $199K | Hold |
2,884
| – | – | ﹤0.01% | 1013 |
|
|
2024
Q1 | $209K | Hold |
2,884
| – | – | ﹤0.01% | 1011 |
|
|
2023
Q4 | $177K | Hold |
2,884
| – | – | ﹤0.01% | 1061 |
|
|
2023
Q3 | $164K | Sell |
2,884
-9
| -0.3% | -$544 | ﹤0.01% | 1077 |
|
|
2023
Q2 | $172K | Sell |
2,893
-4
| -0.1% | -$239 | ﹤0.01% | 1091 |
|
|
2023
Q1 | $182K | Buy |
2,897
+2,784
| +2,464% | +$174K | ﹤0.01% | 918 |
|
|
2022
Q4 | $7K | Hold |
113
| – | – | ﹤0.01% | 1504 |
|
|
2022
Q3 | $6K | Sell |
113
-2
| -2% | -$111 | ﹤0.01% | 1671 |
|
|
2022
Q2 | $7K | Hold |
115
| – | – | ﹤0.01% | 1454 |
|
|
2022
Q1 | $6K | Hold |
115
| – | – | ﹤0.01% | 1480 |
|
|
2021
Q4 | $7K | Buy |
115
+72
| +167% | +$4.27K | ﹤0.01% | 1501 |
|
|
2021
Q3 | $2K | Sell |
43
-99
| -70% | -$5.44K | ﹤0.01% | 1602 |
|
|
2021
Q2 | $7K | Sell |
142
-59
| -29% | -$2.83K | ﹤0.01% | 1395 |
|
|
2021
Q1 | $9K | Sell |
201
-254
| -56% | -$10.7K | ﹤0.01% | 1330 |
|
|
2020
Q4 | $16K | Buy |
455
+285
| +168% | +$10.1K | ﹤0.01% | 1212 |
|
|
2020
Q3 | $6K | Sell |
170
-102,173
| -100% | -$3.8M | ﹤0.01% | 1175 |
|
|
2020
Q2 | $3.84M | Hold |
102,343
| – | – | 0.01% | 328 |
|
|
2020
Q1 | $3.75M | Buy |
102,343
+31,900
| +45% | +$1.24M | 0.02% | 316 |
|
|
2019
Q4 | $2.85M | Buy |
70,443
+52,400
| +290% | +$1.95M | 0.01% | 470 |
|
|
2019
Q3 | $626K | Buy |
+18,043
| New | +$594K | ﹤0.01% | 821 |
|
|
2017
Q4 | – | Sell |
-33,900
| Closed | -$1.7M | – | 1782 |
|
|
2017
Q3 | $1.7M | Buy |
33,900
+9,400
| +38% | +$480K | 0.01% | 491 |
|
|
2017
Q2 | $1.29M | Hold |
24,500
| – | – | 0.01% | 590 |
|
|
2017
Q1 | $1.36M | Sell |
24,500
-4,247
| -15% | -$234K | 0.01% | 617 |
|
|
2016
Q4 | $1.5M | Sell |
28,747
-15,453
| -35% | -$746K | 0.01% | 606 |
|
|
2016
Q3 | $2.13M | Buy |
+44,200
| New | +$2.24M | 0.01% | 425 |
|
|
2015
Q1 | – | Sell |
-382
| Closed | -$13K | – | 1557 |
|
|
2014
Q4 | $13K | Buy |
+382
| New | +$12.7K | ﹤0.01% | 1205 |
|
|
2014
Q3 | – | Sell |
-61
| Closed | -$2K | – | 1348 |
|
|
2014
Q2 | $2K | Buy |
+61
| New | +$1.95K | ﹤0.01% | 1289 |
|
Other funds holding PBH
AI
BIP
Bessemer Group's PBH Position: Q2 2026 in Review
Bessemer Group reduced its Prestige Consumer Healthcare (PBH) stake by 50% in Q2 2026, selling an estimated $9.68M and leaving 186,321 shares worth $8.81M. The position accounts for 0.01% of the portfolio, ranked #428.
Bessemer Group first reported a position in PBH in Q2 2014 and has held it in 35 quarters since. The position peaked at $31.1M in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Bessemer Group held 186,321 shares of Prestige Consumer Healthcare worth $8.81M as of Q2 2026.
- Bessemer Group sold 188,370 Prestige Consumer Healthcare shares in Q2 2026, an estimated $9.68M.
- Prestige Consumer Healthcare made up 0.01% of Bessemer Group's portfolio in Q2 2026, its #428 holding.
- Bessemer Group first reported a position in Prestige Consumer Healthcare in Q2 2014 and has held it in 35 quarters since.
- Bessemer Group's Prestige Consumer Healthcare position peaked at $31.1M in Q1 2025.
- 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.